41. 巨細胞性動脈炎 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 131 / 薬物数 : 139 - (DrugBank : 36) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 125
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
Southend Hospital
2012 - EUCTR2011-005090-22-GB United Kingdom;
18F-FDG
Svendborg Hospital
2017 - NCT02985424 Denmark;
18F]PEG-Folate
University Medical Center Groningen, Department of Rheumatology and Clinical Immunology
2021 Phase 2 EUCTR2020-001019-26-NL Netherlands;
ABT-494
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AIN457
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004809-31-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-PT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2018 Phase 2 EUCTR2018-002610-12-DE Germany;
Abatacept
Bristol-Myers Squibb
2017 Phase 3 NCT03192969 Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States;
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
2008 Phase 2 NCT00556439 Canada;United States;
University of Pennsylvania
2021 Phase 3 NCT04474847 United States;
Adalimumab
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00305539 France;
Alendronate versus alfacalcidol (1-alpha OH vitamin D)
UMC Utrecht
2000 Phase 3 NCT00138983 Netherlands;
Anti-thymocyte globulin
Fairview University Medical Center
2000 - NCT00006055 United States;
Autologous Peripheral Blood Stem Cell Transplantation
Fairview University Medical Center
2000 - NCT00006055 United States;
BOSENTAN MYLAN
CHU de Nice
2019 Phase 3 EUCTR2018-004072-35-FR France;
Baricitinib
Matthew J Koster
2017 Phase 2 NCT03026504 United States;
Blood samples
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
2019 Phase 2 NCT03711448 France;
2017 - NCT03313102 France;
2015 - NCT02857192 France;
CNTO 136
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
CNTO1959
JANSSEN CILAG INTERNATIONAL NV
2020 Phase 2 EUCTR2020-000622-26-IT Belgium;Canada;France;Germany;Italy;Poland;Spain;United States;
Janssen-Cilag International N.V.
2021 Phase 2 EUCTR2020-000622-26-DE Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
Capsule di prednisone
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Combination Product: mavrilimumab
Kiniksa Pharmaceuticals, Ltd.
2018 Phase 2 NCT03827018 Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Cortancyl ®
SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
2018 Phase 3 EUCTR2017-002988-18-IT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Sanofi-Aventis Recherche & Développement
2019 Phase 3 EUCTR2017-002988-18-SI Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-PT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-HR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-GB Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FI Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-DK Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-AT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-SE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-NL Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-HU Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-ES Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-EE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-DE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-BE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Corticoids+ tocilizumab 8mg/Kg/4 weeks
Centre Hospitalier Universitaire Dijon
2013 Phase 2 NCT01910038 France;
Corticosteroid (CS)
AbbVie
2019 Phase 3 NCT03725202 Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States;
Corticosteroids
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Corticosteroids for Systemic Use
University Hospital, Caen
2020 Phase 3 NCT04012905 -
Cosentyx
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004809-31-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-PT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2018 Phase 2 EUCTR2018-002610-12-DE Germany;
Cosentyx 300 mg solution for injection in pre-filled syringe
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FI Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DK Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Cosentyx 300mg solution for injection in pre-filled syringe
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Cyclophosphamide
Fairview University Medical Center
2000 - NCT00006055 United States;
Cyclosporine
Fairview University Medical Center
2000 - NCT00006055 United States;
Dotatate
University of Alberta
2019 Phase 2 NCT03812302 Canada;
Encorton
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Filgrastim
Fairview University Medical Center
2000 - NCT00006055 United States;
GSK2973327
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Gevokizumab
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;
Glucocorticoid Treatment
Bristol-Myers Squibb
2017 Phase 3 NCT03192969 Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States;
Glucocorticoids
University Hospital Inselspital, Berne
2018 Phase 1/Phase 2 NCT03745586 Italy;Switzerland;
Guselkumab
Janssen Research & Development, LLC
2020 Phase 2 NCT04633447 Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
Janssen-Cilag International N.V.
2021 Phase 2 EUCTR2020-000622-26-DE Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
H02AB09
Copenhagen University Hospital Rigshospitalet
2022 Phase 4 EUCTR2021-002528-18-DK Denmark;
Hydrokortison orion
Copenhagen University Hospital Rigshospitalet
2022 Phase 4 EUCTR2021-002528-18-DK Denmark;
Hydroxychloroquine
University Hospital, Toulouse
2002 Phase 3 NCT00430807 France;
Infliximab
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Centocor, Inc.
2003 Phase 2 NCT00076726 Belgium;Italy;Spain;United Kingdom;United States;
KPL-301
Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
2019 Phase 2 EUCTR2018-001003-36-HR Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001003-36-DE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-SI Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-NL Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-IT Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-GB Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-ES Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-EE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-BE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Kevzara ®
SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
2018 Phase 3 EUCTR2017-002988-18-IT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Sanofi-Aventis Recherche & Développement
2019 Phase 3 EUCTR2017-002988-18-SI Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-PT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-HR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-GB Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FI Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-DK Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-AT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-SE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-NL Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-HU Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-ES Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-EE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-DE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-BE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Lodotra (delayed release prednisolone)
Southend Hospital
2012 - EUCTR2011-005090-22-GB United Kingdom;
METOJECT
CHU Dijon Bourgogne
2019 Phase 3 EUCTR2018-002826-22-FR France;
Methotrexate
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
The Cleveland Clinic
1994 Phase 2 NCT00004686 -
Methotrexate treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
Methylprednisolone
Fairview University Medical Center
2000 - NCT00006055 United States;
Naltrexone Hydrochloride
University of Pennsylvania
2019 Phase 2 NCT03482479 United States;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
Over encapsulated prednisone
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
PET10
University of Aarhus
2014 - NCT03285945 Denmark;
PET3
University of Aarhus
2014 - NCT03285945 Denmark;
Pr
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
PredniSONE Tablets USP,
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FI Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DK Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Prednisolon 1 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 10 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 20 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 5 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolone
Novartis Pharmaceuticals
2019 Phase 2 NCT03765788 Germany;
Prednisolone 5 mg JENAPHARM
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisone
Fairview University Medical Center
2000 - NCT00006055 United States;
GlaxoSmithKline
2015 Phase 3 NCT02531633 Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Kiniksa Pharmaceuticals, Ltd.
2018 Phase 2 NCT03827018 Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Massachusetts General Hospital
2018 Phase 4 NCT03726749 United States;
2016 Phase 1/Phase 2 NCT02955147 United States;
Sanofi
2018 Phase 3 NCT03600805 Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
The Cleveland Clinic
1994 Phase 2 NCT00004686 -
Prednisone Capsules
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Prednisone Tablets, USP
Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
2018 Phase 2 EUCTR2018-001003-36-GB Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Prednisone and ustekinumab treatment
Centre Hospitalier Universitaire Dijon
2019 Phase 2 NCT03711448 France;
Prednisone therapy and pharmacokinetic
University Hospital, Caen
2009 Phase 4 NCT01400464 France;
Prednisone treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
2019 Phase 2 NCT03711448 France;
Rituximab
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Ro 001-9265/F02
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 001-9265/F03
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 001-9265/F04
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 487-7533/F10-04
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
RoActemra
CHU Dijon Bourgogne
2019 Phase 3 EUCTR2018-002826-22-FR France;
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
RoActemra 162 mg solution for injection in pre-filled syringe
ROCHE SAS
2017 Phase 3 EUCTR2016-002716-41-FR France;
S78989
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;
Sarilumab SAR153191
Sanofi
2018 Phase 3 NCT03600805 Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Secukinumab
Novartis Pharmaceuticals
2021 Phase 3 NCT04930094 Australia;Belgium;Finland;France;Germany;Hungary;Poland;Portugal;Spain;Switzerland;Turkey;United States;
Secukinumab 300 mg, s.c.
Novartis Pharmaceuticals
2019 Phase 2 NCT03765788 Germany;
Sirukumab
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline
2015 Phase 3 NCT02531633 Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
TOCILIZUMAB SC
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Tocilizumab
Clinical ImmunologySaitama Medical Center, Saitama Medical Universitity
Assistance Publique - Hôpitaux de Paris
2021 Phase 3 NCT04888221 France;
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Department of Rheumatology &
Hoffmann-La Roche
2019 Phase 1 NCT03923738 Switzerland;
2017 Phase 3 NCT03202368 France;
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Hospital of Prato
2015 Phase 4 NCT03244709 Italy;
Massachusetts General Hospital
2018 Phase 4 NCT03726749 United States;
University Hospital Inselspital, Berne
2018 Phase 1/Phase 2 NCT03745586 Italy;Switzerland;
Tocilizumab + Glucocorticoids (GCs)
University Hospital Inselspital, Berne
2011 Phase 2 NCT01450137 Switzerland;
Tocilizumab Prefilled Syringe
Syneos Health
2021 Phase 1 NCT04885829 Australia;New Zealand;
Tocilizumab SC
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Tocilizumab and IV steroids combination
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
2020 Phase 2 NCT04239196 France;
Tocilizumab treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
Treatment
Centre Hospitalier Universitaire de Nice
2019 Phase 3 NCT03841734 France;
Upadacitinib
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie
2019 Phase 3 NCT03725202 Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Ustekinumab
Massachusetts General Hospital
2016 Phase 1/Phase 2 NCT02955147 United States;
XOMA 052
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;
Southend Hospital
2012 - EUCTR2011-005090-22-GB United Kingdom;
18F-FDG
Svendborg Hospital
2017 - NCT02985424 Denmark;
18F]PEG-Folate
University Medical Center Groningen, Department of Rheumatology and Clinical Immunology
2021 Phase 2 EUCTR2020-001019-26-NL Netherlands;
ABT-494
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AIN457
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004809-31-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-PT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2018 Phase 2 EUCTR2018-002610-12-DE Germany;
Abatacept
Bristol-Myers Squibb
2017 Phase 3 NCT03192969 Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States;
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
2008 Phase 2 NCT00556439 Canada;United States;
University of Pennsylvania
2021 Phase 3 NCT04474847 United States;
Adalimumab
Assistance Publique - Hôpitaux de Paris
2006 Phase 3 NCT00305539 France;
Alendronate versus alfacalcidol (1-alpha OH vitamin D)
UMC Utrecht
2000 Phase 3 NCT00138983 Netherlands;
Anti-thymocyte globulin
Fairview University Medical Center
2000 - NCT00006055 United States;
Autologous Peripheral Blood Stem Cell Transplantation
Fairview University Medical Center
2000 - NCT00006055 United States;
BOSENTAN MYLAN
CHU de Nice
2019 Phase 3 EUCTR2018-004072-35-FR France;
Baricitinib
Matthew J Koster
2017 Phase 2 NCT03026504 United States;
Blood samples
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
2019 Phase 2 NCT03711448 France;
2017 - NCT03313102 France;
2015 - NCT02857192 France;
CNTO 136
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
CNTO1959
JANSSEN CILAG INTERNATIONAL NV
2020 Phase 2 EUCTR2020-000622-26-IT Belgium;Canada;France;Germany;Italy;Poland;Spain;United States;
Janssen-Cilag International N.V.
2021 Phase 2 EUCTR2020-000622-26-DE Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
Capsule di prednisone
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Combination Product: mavrilimumab
Kiniksa Pharmaceuticals, Ltd.
2018 Phase 2 NCT03827018 Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Cortancyl ®
SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
2018 Phase 3 EUCTR2017-002988-18-IT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Sanofi-Aventis Recherche & Développement
2019 Phase 3 EUCTR2017-002988-18-SI Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-PT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-HR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-GB Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FI Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-DK Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-AT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-SE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-NL Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-HU Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-ES Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-EE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-DE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-BE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Corticoids+ tocilizumab 8mg/Kg/4 weeks
Centre Hospitalier Universitaire Dijon
2013 Phase 2 NCT01910038 France;
Corticosteroid (CS)
AbbVie
2019 Phase 3 NCT03725202 Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States;
Corticosteroids
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Corticosteroids for Systemic Use
University Hospital, Caen
2020 Phase 3 NCT04012905 -
Cosentyx
NOVARTIS PHARMA AG
2021 Phase 3 EUCTR2020-004809-31-IT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-PT Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FR Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Novartis Pharma GmbH
2018 Phase 2 EUCTR2018-002610-12-DE Germany;
Cosentyx 300 mg solution for injection in pre-filled syringe
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FI Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DK Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Cosentyx 300mg solution for injection in pre-filled syringe
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Cyclophosphamide
Fairview University Medical Center
2000 - NCT00006055 United States;
Cyclosporine
Fairview University Medical Center
2000 - NCT00006055 United States;
Dotatate
University of Alberta
2019 Phase 2 NCT03812302 Canada;
Encorton
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Filgrastim
Fairview University Medical Center
2000 - NCT00006055 United States;
GSK2973327
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Gevokizumab
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;
Glucocorticoid Treatment
Bristol-Myers Squibb
2017 Phase 3 NCT03192969 Australia;Austria;Belgium;Bulgaria;Canada;Denmark;Estonia;France;Germany;Greece;Ireland;Italy;Netherlands;Poland;Romania;Serbia;Spain;Sweden;Switzerland;United Kingdom;United States;
Glucocorticoids
University Hospital Inselspital, Berne
2018 Phase 1/Phase 2 NCT03745586 Italy;Switzerland;
Guselkumab
Janssen Research & Development, LLC
2020 Phase 2 NCT04633447 Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
Janssen-Cilag International N.V.
2021 Phase 2 EUCTR2020-000622-26-DE Belgium;Canada;France;Germany;Israel;Italy;Poland;Spain;United States;
H02AB09
Copenhagen University Hospital Rigshospitalet
2022 Phase 4 EUCTR2021-002528-18-DK Denmark;
Hydrokortison orion
Copenhagen University Hospital Rigshospitalet
2022 Phase 4 EUCTR2021-002528-18-DK Denmark;
Hydroxychloroquine
University Hospital, Toulouse
2002 Phase 3 NCT00430807 France;
Infliximab
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Centocor, Inc.
2003 Phase 2 NCT00076726 Belgium;Italy;Spain;United Kingdom;United States;
KPL-301
Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
2019 Phase 2 EUCTR2018-001003-36-HR Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2019 Phase 2 EUCTR2018-001003-36-DE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-SI Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-NL Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-IT Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-GB Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-ES Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-EE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
2018 Phase 2 EUCTR2018-001003-36-BE Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Kevzara ®
SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT
2018 Phase 3 EUCTR2017-002988-18-IT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Sanofi-Aventis Recherche & Développement
2019 Phase 3 EUCTR2017-002988-18-SI Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-PT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-HR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-GB Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FR Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-FI Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Norway;Portugal;Russian Federation;Serbia;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-DK Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2019 Phase 3 EUCTR2017-002988-18-AT Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-SE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-NL Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-HU Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-ES Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-EE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-DE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
2018 Phase 3 EUCTR2017-002988-18-BE Argentina;Australia;Austria;Belgium;Canada;Chile;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Lodotra (delayed release prednisolone)
Southend Hospital
2012 - EUCTR2011-005090-22-GB United Kingdom;
METOJECT
CHU Dijon Bourgogne
2019 Phase 3 EUCTR2018-002826-22-FR France;
Methotrexate
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
The Cleveland Clinic
1994 Phase 2 NCT00004686 -
Methotrexate treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
Methylprednisolone
Fairview University Medical Center
2000 - NCT00006055 United States;
Naltrexone Hydrochloride
University of Pennsylvania
2019 Phase 2 NCT03482479 United States;
Nivolumab
Alliance Foundation Trials, LLC.
2019 Phase 1 NCT03656627 United States;
Over encapsulated prednisone
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
PET10
University of Aarhus
2014 - NCT03285945 Denmark;
PET3
University of Aarhus
2014 - NCT03285945 Denmark;
Pr
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
PredniSONE Tablets USP,
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Novartis Pharma AG
2021 Phase 3 EUCTR2020-004809-31-NO Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-FI Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DK Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-DE Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
2021 Phase 3 EUCTR2020-004809-31-BG Argentina;Australia;Belgium;Brazil;Bulgaria;Canada;Czechia;Denmark;Estonia;Finland;France;Germany;Guatemala;Hungary;Italy;Netherlands;New Zealand;Norway;Poland;Portugal;Russian Federation;South Africa;Spain;Sweden;Switzerland;Turkey;United Kingdom;United States;
Prednisolon 1 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 10 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 20 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolon 5 mg JENAPHARM
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisolone
Novartis Pharmaceuticals
2019 Phase 2 NCT03765788 Germany;
Prednisolone 5 mg JENAPHARM
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Prednisone
Fairview University Medical Center
2000 - NCT00006055 United States;
GlaxoSmithKline
2015 Phase 3 NCT02531633 Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
Hoffmann-La Roche
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Kiniksa Pharmaceuticals, Ltd.
2018 Phase 2 NCT03827018 Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Massachusetts General Hospital
2018 Phase 4 NCT03726749 United States;
2016 Phase 1/Phase 2 NCT02955147 United States;
Sanofi
2018 Phase 3 NCT03600805 Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
The Cleveland Clinic
1994 Phase 2 NCT00004686 -
Prednisone Capsules
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
Prednisone Tablets, USP
Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp.
2018 Phase 2 EUCTR2018-001003-36-GB Australia;Belgium;Croatia;Estonia;Germany;Ireland;Italy;Netherlands;New Zealand;Poland;Serbia;Slovenia;Spain;United Kingdom;United States;
Prednisone and ustekinumab treatment
Centre Hospitalier Universitaire Dijon
2019 Phase 2 NCT03711448 France;
Prednisone therapy and pharmacokinetic
University Hospital, Caen
2009 Phase 4 NCT01400464 France;
Prednisone treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
2019 Phase 2 NCT03711448 France;
Rituximab
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Ro 001-9265/F02
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 001-9265/F03
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 001-9265/F04
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Ro 487-7533/F10-04
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-SE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-PL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
RoActemra
CHU Dijon Bourgogne
2019 Phase 3 EUCTR2018-002826-22-FR France;
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DK Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
RoActemra 162 mg solution for injection in pre-filled syringe
ROCHE SAS
2017 Phase 3 EUCTR2016-002716-41-FR France;
S78989
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;
Sarilumab SAR153191
Sanofi
2018 Phase 3 NCT03600805 Argentina;Australia;Austria;Belgium;Canada;Croatia;Denmark;Estonia;Finland;France;Germany;Hungary;Israel;Italy;Netherlands;Portugal;Russian Federation;Slovenia;Spain;Sweden;Switzerland;United Kingdom;United States;
Secukinumab
Novartis Pharmaceuticals
2021 Phase 3 NCT04930094 Australia;Belgium;Finland;France;Germany;Hungary;Poland;Portugal;Spain;Switzerland;Turkey;United States;
Secukinumab 300 mg, s.c.
Novartis Pharmaceuticals
2019 Phase 2 NCT03765788 Germany;
Sirukumab
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT
2016 Phase 3 EUCTR2015-001758-14-IT Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
GlaxoSmithKline
2015 Phase 3 NCT02531633 Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
GlaxoSmithKline Research and Development Limited
2016 Phase 3 EUCTR2015-001758-14-NL Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-HU Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2016 Phase 3 EUCTR2015-001758-14-BG Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-ES Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-DE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;United Kingdom;United States;
2015 Phase 3 EUCTR2015-001758-14-BE Australia;Belgium;Bulgaria;France;Germany;Hungary;Italy;Netherlands;New Zealand;Poland;Spain;Sweden;United Kingdom;United States;
TOCILIZUMAB SC
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-NL Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Tocilizumab
Clinical ImmunologySaitama Medical Center, Saitama Medical Universitity
Assistance Publique - Hôpitaux de Paris
2021 Phase 3 NCT04888221 France;
Cambridge University Hospitals NHS Foundation Trust
2020 Phase 2 EUCTR2019-003964-30-GB United Kingdom;
Department of Rheumatology &
Hoffmann-La Roche
2019 Phase 1 NCT03923738 Switzerland;
2017 Phase 3 NCT03202368 France;
2013 Phase 3 NCT01791153 Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Hospital of Prato
2015 Phase 4 NCT03244709 Italy;
Massachusetts General Hospital
2018 Phase 4 NCT03726749 United States;
University Hospital Inselspital, Berne
2018 Phase 1/Phase 2 NCT03745586 Italy;Switzerland;
Tocilizumab + Glucocorticoids (GCs)
University Hospital Inselspital, Berne
2011 Phase 2 NCT01450137 Switzerland;
Tocilizumab Prefilled Syringe
Syneos Health
2021 Phase 1 NCT04885829 Australia;New Zealand;
Tocilizumab SC
F. Hoffmann-La Roche Ltd
2013 Phase 3 EUCTR2011-006022-25-PT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-IT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-GB Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-ES Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-DE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-BE Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
2013 Phase 3 EUCTR2011-006022-25-AT Austria;Belgium;Canada;Denmark;France;Germany;Italy;Netherlands;Norway;Poland;Portugal;Spain;Sweden;United Kingdom;United States;
Tocilizumab and IV steroids combination
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
2020 Phase 2 NCT04239196 France;
Tocilizumab treatment
Centre Hospitalier Universitaire Dijon
2020 Phase 3 NCT03892785 France;
Treatment
Centre Hospitalier Universitaire de Nice
2019 Phase 3 NCT03841734 France;
Upadacitinib
ABBVIE DEUTSCHLAND GMBH & CO. KG
2019 Phase 3 EUCTR2017-003978-13-IT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
AbbVie
2019 Phase 3 NCT03725202 Australia;Austria;Belgium;Canada;Czechia;Denmark;France;Germany;Greece;Hungary;Israel;Italy;Japan;Netherlands;New Zealand;Norway;Portugal;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States;
AbbVie Deutschland GmbH & Co. KG
2019 Phase 3 EUCTR2017-003978-13-RO Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Romania;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-PT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-NL Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-HU Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-GR Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-FR Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-ES Australia;Austria;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DK Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-DE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-BE Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
2019 Phase 3 EUCTR2017-003978-13-AT Australia;Austria;Belgium;Canada;Denmark;France;Germany;Greece;Hungary;Japan;Netherlands;New Zealand;Portugal;Russian Federation;Spain;United States;
Ustekinumab
Massachusetts General Hospital
2016 Phase 1/Phase 2 NCT02955147 United States;
XOMA 052
Institut de Recherches Internationales Servier (IRIS)
2015 - EUCTR2013-002778-38-IE Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-FI Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-EE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2015 - EUCTR2013-002778-38-BE Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-GB Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 Phase 2 EUCTR2013-002778-38-CZ Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-DK Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2014 - EUCTR2013-002778-38-AT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;France;Ireland;Italy;Norway;Poland;Russian Federation;Spain;Switzerland;United Kingdom;
2013 Phase 2 EUCTR2013-002778-38-IT Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Italy;Russian Federation;Spain;United Kingdom;
Laboratorios Servier SL
2014 - EUCTR2013-002778-38-ES Australia;Austria;Belgium;Canada;Czech Republic;Denmark;Estonia;Finland;Ireland;Russian Federation;Spain;United Kingdom;